Dipyrone Antipyretic Use Reported By 38% Of San Diego Hispanics - Survey
This article was originally published in The Tan Sheet
Executive Summary
More than one-third of Hispanic patients surveyed in two San Diego community medical clinics reported using Hoechst AG's Neo-melubrina (dipyrone), an antipyretic drug banned by FDA but available over-the-counter in many European and Latin American countries, including Mexico.